SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-027344
Filing Date
2023-08-09
Accepted
2023-08-09 16:05:41
Documents
17
Period of Report
2023-08-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 47166
2 ex99-1.htm EX-99.1 172298
3 ex99-2.htm EX-99.2 195584
4 ex99-1_001.jpg GRAPHIC 14259
5 ex99-2_001.jpg GRAPHIC 14259
  Complete submission text file 0001493152-23-027344.txt   727384

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE hrow-20230809.xsd EX-101.SCH 3944
7 XBRL DEFINITION FILE hrow-20230809_def.xml EX-101.DEF 27404
8 XBRL LABEL FILE hrow-20230809_lab.xml EX-101.LAB 37859
9 XBRL PRESENTATION FILE hrow-20230809_pre.xml EX-101.PRE 26021
11 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6235
Mailing Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215
Business Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215 615.733.4731
HARROW HEALTH, INC. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35814 | Film No.: 231155092
SIC: 2834 Pharmaceutical Preparations